BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20138113)

  • 1. Histories of major depression and premenstrual dysphoric disorder: Evidence for phenotypic differences.
    Klatzkin RR; Lindgren ME; Forneris CA; Girdler SS
    Biol Psychol; 2010 May; 84(2):235-47. PubMed ID: 20138113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menstrual cycle, beta-endorphins, and pain sensitivity in premenstrual dysphoric disorder.
    Straneva PA; Maixner W; Light KC; Pedersen CA; Costello NL; Girdler SS
    Health Psychol; 2002 Jul; 21(4):358-67. PubMed ID: 12090678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopregnanolone serum concentrations and diurnal cortisol secretion in women with premenstrual dysphoric disorder.
    Segebladh B; Bannbers E; Moby L; Nyberg S; Bixo M; Bäckström T; Sundström Poromaa I
    Arch Womens Ment Health; 2013 Apr; 16(2):131-7. PubMed ID: 23329007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress, mood, and cortisol during daily life in women with Premenstrual Dysphoric Disorder (PMDD).
    Beddig T; Reinhard I; Kuehner C
    Psychoneuroendocrinology; 2019 Nov; 109():104372. PubMed ID: 31357135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Historical sexual abuse and current thyroid axis profiles in women with premenstrual dysphoric disorder.
    Girdler SS; Thompson KS; Light KC; Leserman J; Pedersen CA; Prange AJ
    Psychosom Med; 2004; 66(3):403-10. PubMed ID: 15184704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.
    Girdler SS; Straneva PA; Light KC; Pedersen CA; Morrow AL
    Biol Psychiatry; 2001 May; 49(9):788-97. PubMed ID: 11331087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personal history of major depression may put women at risk for premenstrual dysphoric symptomatology.
    Accortt EE; Kogan AV; Allen JJ
    J Affect Disord; 2013 Sep; 150(3):1234-7. PubMed ID: 23800446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression.
    Ahrens T; Deuschle M; Krumm B; van der Pompe G; den Boer JA; Lederbogen F
    Psychosom Med; 2008 May; 70(4):461-7. PubMed ID: 18378864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premenstrual dysphoric disorder and risk for major depressive disorder: a preliminary study.
    Hartlage SA; Arduino KE; Gehlert S
    J Clin Psychol; 2001 Dec; 57(12):1571-8. PubMed ID: 11745598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls.
    Girdler SS; Sherwood A; Hinderliter AL; Leserman J; Costello NL; Straneva PA; Pedersen CA; Light KC
    Psychosom Med; 2003; 65(5):849-56. PubMed ID: 14508031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blunted Cortisol Response to Acute Psychosocial Stress in Women With Premenstrual Dysphoric Disorder.
    Hamidovic A; Davis J; Soumare F
    Int J Neuropsychopharmacol; 2024 Mar; 27(3):. PubMed ID: 38451747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menstrual mood disorders are associated with blunted sympathetic reactivity to stress.
    Klatzkin RR; Bunevicius A; Forneris CA; Girdler S
    J Psychosom Res; 2014 Jan; 76(1):46-55. PubMed ID: 24360141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histories of sexual abuse are associated with differential effects of clonidine on autonomic function in women with premenstrual dysphoric disorder.
    Bunevicius R; Hinderliter AL; Light KC; Leserman J; Pedersen CA; Girdler SS
    Biol Psychol; 2005 Jul; 69(3):281-96. PubMed ID: 15925031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder.
    Girdler SS; Leserman J; Bunevicius R; Klatzkin R; Pedersen CA; Light KC
    Health Psychol; 2007 Mar; 26(2):201-13. PubMed ID: 17385972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the Tridimensional Personality Questionnaire in premenstrual dysphoric disorder and major depressive disorder.
    Hsu SC; Liu CY; Hsiao MC
    Compr Psychiatry; 2007; 48(4):366-70. PubMed ID: 17560958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women.
    Klatzkin RR; Morrow AL; Light KC; Pedersen CA; Girdler SS
    Biol Psychol; 2006 Jan; 71(1):2-11. PubMed ID: 15951099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstetrician-gynecologists' attitudes towards premenstrual dysphoric disorder and major depressive disorder.
    Hill LD; Greenberg BD; Holzman GB; Schulkin J
    J Psychosom Obstet Gynaecol; 2001 Dec; 22(4):241-50. PubMed ID: 11840578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of histories of depression and PMDD diagnosis with allopregnanolone concentrations following the oral administration of micronized progesterone.
    Klatzkin RR; Morrow AL; Light KC; Pedersen CA; Girdler SS
    Psychoneuroendocrinology; 2006 Nov; 31(10):1208-19. PubMed ID: 17046166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPA axis reactivity to pharmacologic and psychological stressors in euthymic women with histories of postpartum versus major depression.
    Ferguson EH; Di Florio A; Pearson B; Putnam KT; Girdler S; Rubinow DR; Meltzer-Brody S
    Arch Womens Ment Health; 2017 Jun; 20(3):411-420. PubMed ID: 28251369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of cardiovascular and neuroendocrine responses to stress in premenstrual dysphoric disorder.
    Girdler SS; Pedersen CA; Straneva PA; Leserman J; Stanwyck CL; Benjamin S; Light KC
    Psychiatry Res; 1998 Nov; 81(2):163-78. PubMed ID: 9858034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.